Cargando…

Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications

Detalles Bibliográficos
Autores principales: Friberger, Ida, Jussing, Emma, Han, Jinming, Goos, Jeroen A. C. M., Siikanen, Jonathan, Kaipe, Helen, Lambert, Mélanie, Harris, Robert A., Samén, Erik, Carlsten, Mattias, Holmin, Staffan, Tran, Thuy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085663/
https://www.ncbi.nlm.nih.gov/pubmed/35174429
http://dx.doi.org/10.1007/s11307-022-01709-1
_version_ 1784703867238219776
author Friberger, Ida
Jussing, Emma
Han, Jinming
Goos, Jeroen A. C. M.
Siikanen, Jonathan
Kaipe, Helen
Lambert, Mélanie
Harris, Robert A.
Samén, Erik
Carlsten, Mattias
Holmin, Staffan
Tran, Thuy A.
author_facet Friberger, Ida
Jussing, Emma
Han, Jinming
Goos, Jeroen A. C. M.
Siikanen, Jonathan
Kaipe, Helen
Lambert, Mélanie
Harris, Robert A.
Samén, Erik
Carlsten, Mattias
Holmin, Staffan
Tran, Thuy A.
author_sort Friberger, Ida
collection PubMed
description
format Online
Article
Text
id pubmed-9085663
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-90856632022-05-11 Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications Friberger, Ida Jussing, Emma Han, Jinming Goos, Jeroen A. C. M. Siikanen, Jonathan Kaipe, Helen Lambert, Mélanie Harris, Robert A. Samén, Erik Carlsten, Mattias Holmin, Staffan Tran, Thuy A. Mol Imaging Biol Correction Springer International Publishing 2022-02-16 2022 /pmc/articles/PMC9085663/ /pubmed/35174429 http://dx.doi.org/10.1007/s11307-022-01709-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Friberger, Ida
Jussing, Emma
Han, Jinming
Goos, Jeroen A. C. M.
Siikanen, Jonathan
Kaipe, Helen
Lambert, Mélanie
Harris, Robert A.
Samén, Erik
Carlsten, Mattias
Holmin, Staffan
Tran, Thuy A.
Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications
title Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications
title_full Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications
title_fullStr Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications
title_full_unstemmed Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications
title_short Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications
title_sort correction: optimisation of the synthesis and cell labelling conditions for [89zr]zr-oxine and [89zr]zr-dfo-ncs: a direct in vitro comparison in cell types with distinct therapeutic applications
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085663/
https://www.ncbi.nlm.nih.gov/pubmed/35174429
http://dx.doi.org/10.1007/s11307-022-01709-1
work_keys_str_mv AT fribergerida correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications
AT jussingemma correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications
AT hanjinming correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications
AT goosjeroenacm correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications
AT siikanenjonathan correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications
AT kaipehelen correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications
AT lambertmelanie correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications
AT harrisroberta correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications
AT samenerik correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications
AT carlstenmattias correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications
AT holminstaffan correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications
AT tranthuya correctionoptimisationofthesynthesisandcelllabellingconditionsfor89zrzroxineand89zrzrdfoncsadirectinvitrocomparisonincelltypeswithdistincttherapeuticapplications